AMIR MOHARAM

Client: Insmed – Arikayce (DTC)

• Lead agency partner for Arikayce direct-to-consumer (DTC) marketing, driving branded social, lead generation, and CRM initiatives across patient engagement touchpoints.
• Partnered with senior clients in business planning workshops to define and evolve DTC brand strategy and narrative in preparation for MAC-LD market expansion in lieu of anticipated 2027 indication launch.
• Helped plan the development of an unbranded DSA strategy (launching in 2026) to build disease awareness and accelerate patient identification ahead of the 2027 MAC-LD indication.
• Oversaw a combined $8M tactical scope ($5.7M for refractory MAC; $2.3M for MAC-LD), ensuring financial transparency and consistently delivering on-strategy, on-budget, and on-time execution while reporting to the SVP business lead.
• Acted as day-to-day strategic advisor to brand managers, identifying business growth opportunities while ensuring flawless execution of ongoing programs.

Client: Weight Loss & Wellness Center, led by Dr. Saniea Majid

• Provide freelance consulting as fractional CMO, leading brand management, marketing strategy, and campaign execution for a regional leader in obesity and weight loss.
• Designed omnichannel marketing programs (social, CRM, website, landing pages) to generate leads, nurture prospective patients, and convert them into active clients.
• Built and implemented patient segmentation strategies with tailored messaging for distinct personas (menopause, post-surgery, adolescent, event-driven), driving stronger engagement and conversion outcomes.
• Expanded therapeutic expertise into obesity and weight loss, complementing deep experience in immunology and rare disease.
• Act as executive advisor to the CEO, aligning marketing investments with growth objectives and ensuring measurable ROI on campaigns.

• Client: Johnson & Johnson, Immunology portfolio (Rheumatology) - TREMFYA for PsA | HCP
• Client: Johnson & Johnson Immunology (Gastroenterology) - STELARA CD and UC | HCP
• Spearheaded Tremfya PsA HCP promotional tactics from an agency perspective, contributing to a record-high 11.5% New-to-Brand (NtB) share, up from 9.5% in the four months following the launch of the iVis and core tactics.
• Partnered with Creative and Strategy Teams to identify organic growth opportunities to both brand and agency, securing incremental funds for the agency through high-value tactical recommendations.
• Managed a $5M+ tactical scope, delivering exceptional client satisfaction across initiatives, including Rheum iVis, website overhaul, gamified experiences, and social campaigns.
• Led workstreams for market research, business planning, and Go-to-Market (GTM) efforts, including designing discussion guides and stimuli for messaging strategy refinement.
• Recognized for financial management excellence, ensuring all deliverables consistently stayed within budget.
• Led the execution of strategic campaigns for Stelara GI HCP (CD and UC), including the "Time Is Now" initiative, improving HCP engagement during major conventions like DDW and ACG, while reporting directly to the EVP at the time.
• Assisted the EVP in reinstating client relationships affected by former leadership through high-quality tactical execution and nurturing client relationships.

• Client: Johnson & Johnson (J&J), Gastroenterology portfolio - STELARA, Crohn's disease, and ulcerative colitis | HCP
• Client: Johnson. Johnson (J&J), Patient Experience & Customer Solutions (PECS) - Tremfya with Me & Stelara with Me | HCP and DTC.
• Led the execution of strategic campaigns for Stelara GI, including the "Time Is Now" initiative, leveraging new data and improving HCP engagement during major conventions like DDW and ACG.
• Executed professional promotion tactics through the inclusion of new data, updated iVis, and website content.

• Client: Johnson & Johnson (J&J), Rheumatology & Dermatology portfolios - SIMPONI ARIA and TREMFYA for PsA (psoriatic arthritis) and PsO (plaque psoriasis) | DTC
• Led the execution of the Tremfya PsA DTC campaign, achieving a 30% increase in patient conversion rates across digital tactics through the 'EMERGE TREMFYANT' campaign and its derivative tactics.
• Managed key tactical efforts, including OPDP pre-clearance for TV commercials, patient digital wallboards, and addressable social campaigns.
• Supported Account Supervisor, coordinating network clearance efforts.

• Client: Johnson & Johnson (J&J), Rheumatology & Dermatology portfolios - SIMPONI ARIA and TREMFYA for PsA (psoriatic arthritis) and PsO (plaque psoriasis) | DTC
• Maintained up-to-date status documentation and sending timely recaps.
• Supported Account Team in implementing brand tactics.

• Co-led the creation of a comprehensive creative brief as part of the Account Planning Team, serving as the foundation for a high-impact TV campaign for a non-profit organization.